Last reviewed · How we verify

NCT05878821

Effect of Shockwave Therapy on Cervical Myofascial Syndrome in Lactating Women

Completed NA Last updated 8 March 2024
What this trial tests

NA trial testing Shockwave in Cervical Myofascial Pain Syndrome in 30 participants. Completed in 25 September 2023.

Timeline
25 August 2023
Primary endpoint
25 September 2023
25 September 2023

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date25 August 2023
Primary completion25 September 2023
Estimated completion25 September 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 25 to 35, female only, with Cervical Myofascial Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the aim of the study is to determine the effect of shockwave therapy on cervical myofascial pain syndrome in lactating women

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Shockwave

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05878821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing